R1 RCM Inc. (NASDAQ:RCM) Receives Consensus Rating of “Moderate Buy” from Analysts

R1 RCM Inc. (NASDAQ:RCMGet Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $16.87.

RCM has been the topic of a number of recent research reports. Guggenheim cut their price objective on shares of R1 RCM from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, April 5th. Canaccord Genuity Group reduced their price objective on R1 RCM from $17.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, March 20th. Cantor Fitzgerald reiterated an “overweight” rating and set a $20.00 price objective on shares of R1 RCM in a research note on Wednesday, April 10th. SVB Leerink started coverage on R1 RCM in a research note on Monday, February 26th. They issued an “outperform” rating and a $14.00 target price on the stock. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $17.00 price target on shares of R1 RCM in a research report on Tuesday, March 26th.

Check Out Our Latest Analysis on R1 RCM

Insider Buying and Selling

In other news, President John M. Sparby sold 10,046 shares of the company’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $14.33, for a total value of $143,959.18. Following the completion of the transaction, the president now owns 265,986 shares of the company’s stock, valued at $3,811,579.38. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 36.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Retirement Systems of Alabama grew its holdings in shares of R1 RCM by 0.3% in the first quarter. Retirement Systems of Alabama now owns 247,476 shares of the healthcare provider’s stock valued at $3,187,000 after purchasing an additional 856 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in shares of R1 RCM by 4.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 19,601 shares of the healthcare provider’s stock worth $207,000 after buying an additional 908 shares in the last quarter. Van ECK Associates Corp grew its stake in shares of R1 RCM by 20.5% in the 4th quarter. Van ECK Associates Corp now owns 6,141 shares of the healthcare provider’s stock worth $65,000 after buying an additional 1,044 shares in the last quarter. State of Michigan Retirement System raised its position in shares of R1 RCM by 2.5% during the 1st quarter. State of Michigan Retirement System now owns 48,401 shares of the healthcare provider’s stock valued at $623,000 after buying an additional 1,200 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of R1 RCM by 4.2% during the 3rd quarter. Victory Capital Management Inc. now owns 31,275 shares of the healthcare provider’s stock valued at $471,000 after buying an additional 1,250 shares in the last quarter. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Stock Performance

Shares of NASDAQ RCM opened at $12.47 on Friday. R1 RCM has a 1 year low of $8.87 and a 1 year high of $18.70. The company’s 50-day moving average is $12.98 and its 200 day moving average is $11.43. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.57.

R1 RCM Company Profile

(Get Free Report

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.

Further Reading

Analyst Recommendations for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.